- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/62 - Naphtho [c] pyrrolesHydrogenated naphtho [c] pyrroles
Patent holdings for IPC class C07D 209/62
Total number of patents in this class: 29
10-year publication summary
3
|
3
|
2
|
2
|
1
|
1
|
0
|
5
|
1
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Cognition Therapeutics, Inc. | 37 |
5 |
Samsung SDI Co., Ltd. | 7524 |
3 |
Incyte Holdings Corporation | 658 |
3 |
Illumina, Inc. | 3120 |
2 |
Genentech, Inc. | 3897 |
1 |
Merck Patent GmbH | 5873 |
1 |
Shin-Etsu Chemical Co., Ltd. | 5495 |
1 |
California Institute of Technology | 3943 |
1 |
Yamamoto Chemicals, Inc. | 50 |
1 |
The Trustees of the University of Pennsylvania | 4288 |
1 |
Korea Institute of Science and Technology | 2082 |
1 |
Astellas Pharma Inc. | 1112 |
1 |
Colorado State University Research Foundation | 693 |
1 |
N.V. Organon | 534 |
1 |
Osaka Prefecture University Public Corporation | 247 |
1 |
Wave Life Sciences Ltd. | 168 |
1 |
Institut Català D'investigació Química (iciq) | 14 |
1 |
New Iridium Inc | 5 |
1 |
Merck Sharp & Dohme LLC | 3758 |
1 |
Fujian Institute of Research on The Structure of Matter, Chinese Academy of Scie | 4 |
1 |
Other owners | 0 |